Summary of Study ST003052
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001901. The data can be accessed directly via it's Project DOI: 10.21228/M80H83 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST003052 |
Study Title | Synaptic vesicle lipidomics captures signatures of aging and synucleinopathy |
Study Summary | Untargeted synaptic vesicle lipidomics analysis: Synaptic vesicles were isolated from six animals each of 1-month, 3-month, and 10-month old wild-type mice (JAX strain #: 000664), α-synuclein knockout mice (JAX strain #: 023837), and α-synuclein BAC mice (JAX strain #: 023837) using subcellular fractionation. Vesicles were concentrated using 3 kDa cutoff Amicon ultra centrifugal devices (Millipore). Pellets were resuspended in 100 µl water and homogenized. Protein concentration was determined using absorption at 280 nm. Samples were adjusted to the same concentration to a final volume of 200 µl in 50% methanol. All samples were mixed with a panel of 15 lipid internal standards (Splash LipidMix lot#330707), followed by lipid extraction as previously reported.1 Lipids were analyzed by LC-MS/MS on an Accucore C30 column (2.1 mm id x 150mm) under both positive and negative ion modes. Raw data files were searched and processed using LipidSearch 5.1 (Thermo Scientific) and normalized against the known amount of internal standard lipids for each sample, allowing for reliably quantitative measurements of all 15 categories of lipids.1 1 Bhawal, R., Fu, Q., Anderson, E.T., Gibson, G.E., and Zhang, S. (2021). Serum Metabolomic and Lipidomic Profiling Reveals Novel Biomarkers of Efficacy for Benfotiamine in Alzheimer's Disease. Int J Mol Sci 22. |
Institute | Weill Cornell Medicine |
Department | Brain and Mind Research Institute |
Laboratory | Burré lab |
Last Name | Burré |
First Name | Jacqueline |
Address | 413 East 69th Street, BB-1024, New York, NY, 10021, USA |
jab2058@med.cornell.edu | |
Phone | 6469626155 |
Submit Date | 2024-01-19 |
Num Groups | 3 |
Total Subjects | 54 |
Raw Data Available | Yes |
Raw Data File Type(s) | raw(Thermo) |
Analysis Type Detail | LC-MS |
Release Date | 2025-04-10 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR001901 |
Project DOI: | doi: 10.21228/M80H83 |
Project Title: | Synaptic vesicle lipidomics captures signatures of aging and synucleinopathy |
Project Type: | MS quantitative analysis |
Project Summary: | Neurotransmitter release occurs through exocytosis of synaptic vesicles. α-Synuclein’s function and dysfunction in Parkinson’s disease and other synucleinopathies is tightly linked to synaptic vesicle binding. Age is the biggest risk factor for synucleinopathy, yet, age- and disease-induced changes in synaptic vesicles remain unexplored. Systematic analysis of the synaptic vesicle lipidome revealed specific changes in two mouse models of synucleinopathy over age. Strikingly, changes in mice lacking α-synuclein were more pronounced than changes in a humanized α-synucleinopathy mouse model, suggesting that loss of α-synuclein function is a major contributor to synaptic dysfunction. These findings not only provide new insights into synaptic vesicle biology and mechanisms of synucleinopathy, but also offer a baseline for further mechanistic exploration of age- and disease-related alterations in synaptic vesicles. |
Institute: | Weill Cornell Medicine |
Department: | Brain and Mind Research Institute |
Laboratory: | Burré lab |
Last Name: | Burré |
First Name: | Jacqueline |
Address: | 413 East 69th Street, BB-1024, New York, NY, 10021, USA |
Email: | jab2058@med.cornell.edu |
Phone: | 6469626155 |
Subject:
Subject ID: | SU003167 |
Subject Type: | Mammal |
Subject Species: | Mus musculus |
Taxonomy ID: | 10090 |
Species Group: | Mammals |
Factors:
Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)
mb_sample_id | local_sample_id | Genotype | Age |
---|---|---|---|
SA331473 | SKB10mo pos1 | alpha-synuclein BAC | 10 months |
SA331474 | SKB10mo neg5 | alpha-synuclein BAC | 10 months |
SA331475 | SKB10mo pos2 | alpha-synuclein BAC | 10 months |
SA331476 | SKB10mo pos6 | alpha-synuclein BAC | 10 months |
SA331477 | SKB10mo pos4 | alpha-synuclein BAC | 10 months |
SA331478 | SKB10mo pos5 | alpha-synuclein BAC | 10 months |
SA331479 | SKB10mo pos3 | alpha-synuclein BAC | 10 months |
SA331480 | SKB10mo neg1 | alpha-synuclein BAC | 10 months |
SA331481 | SKB10mo neg1re | alpha-synuclein BAC | 10 months |
SA331482 | SKB10mo neg6 | alpha-synuclein BAC | 10 months |
SA331483 | SKB10mo neg3 | alpha-synuclein BAC | 10 months |
SA331484 | SKB10mo neg4 | alpha-synuclein BAC | 10 months |
SA331485 | SKB10mo neg2 | alpha-synuclein BAC | 10 months |
SA331461 | SKB1mo neg4 | alpha-synuclein BAC | 1 month |
SA331462 | SKB1mo neg5 | alpha-synuclein BAC | 1 month |
SA331463 | SKB1mo neg3 | alpha-synuclein BAC | 1 month |
SA331464 | SKB1mo pos6 | alpha-synuclein BAC | 1 month |
SA331465 | SKB1mo pos5 | alpha-synuclein BAC | 1 month |
SA331466 | SKB1mo pos4 | alpha-synuclein BAC | 1 month |
SA331467 | SKB1mo neg6 | alpha-synuclein BAC | 1 month |
SA331468 | SKB1mo pos3 | alpha-synuclein BAC | 1 month |
SA331469 | SKB1mo pos2 | alpha-synuclein BAC | 1 month |
SA331470 | SKB1mo neg1 | alpha-synuclein BAC | 1 month |
SA331471 | SKB1mo neg2 | alpha-synuclein BAC | 1 month |
SA331472 | SKB1mo pos1 | alpha-synuclein BAC | 1 month |
SA331486 | SKB3mo neg5 | alpha-synuclein BAC | 3 months |
SA331487 | SKB3mo neg6 | alpha-synuclein BAC | 3 months |
SA331488 | SKB3mo neg4 | alpha-synuclein BAC | 3 months |
SA331489 | SKB3mo neg2 | alpha-synuclein BAC | 3 months |
SA331490 | SKB3mo pos4 | alpha-synuclein BAC | 3 months |
SA331491 | SKB3mo pos5 | alpha-synuclein BAC | 3 months |
SA331492 | SKB3mo pos6 | alpha-synuclein BAC | 3 months |
SA331493 | SKB3mo pos3 | alpha-synuclein BAC | 3 months |
SA331494 | SKB3mo pos2 | alpha-synuclein BAC | 3 months |
SA331495 | SKB3mo neg1 | alpha-synuclein BAC | 3 months |
SA331496 | SKB3mo pos1 | alpha-synuclein BAC | 3 months |
SA331497 | SKB3mo neg3 | alpha-synuclein BAC | 3 months |
SA331510 | aKO10mo neg2 | alpha-synuclein knockout | 10 months |
SA331511 | aKO10mo neg1 | alpha-synuclein knockout | 10 months |
SA331512 | aKO10mo neg3 | alpha-synuclein knockout | 10 months |
SA331513 | aKO10mo pos6 | alpha-synuclein knockout | 10 months |
SA331514 | aKO10mo pos4 | alpha-synuclein knockout | 10 months |
SA331515 | aKO10mo neg4 | alpha-synuclein knockout | 10 months |
SA331516 | aKO10mo pos2 | alpha-synuclein knockout | 10 months |
SA331517 | aKO10mo pos1 | alpha-synuclein knockout | 10 months |
SA331518 | aKO10mo pos5 | alpha-synuclein knockout | 10 months |
SA331519 | aKO10mo pos3 | alpha-synuclein knockout | 10 months |
SA331520 | aKO10mo neg6 | alpha-synuclein knockout | 10 months |
SA331521 | aKO10mo neg5 | alpha-synuclein knockout | 10 months |
SA331498 | aKO1mo neg3 | alpha-synuclein knockout | 1 month |
SA331499 | aKO1mo pos3 | alpha-synuclein knockout | 1 month |
SA331500 | aKO1mo pos4 | alpha-synuclein knockout | 1 month |
SA331501 | aKO1mo pos2 | alpha-synuclein knockout | 1 month |
SA331502 | aKO1mo pos1 | alpha-synuclein knockout | 1 month |
SA331503 | aKO1mo neg1 | alpha-synuclein knockout | 1 month |
SA331504 | aKO1mo neg6 | alpha-synuclein knockout | 1 month |
SA331505 | aKO1mo pos5 | alpha-synuclein knockout | 1 month |
SA331506 | aKO1mo neg5 | alpha-synuclein knockout | 1 month |
SA331507 | aKO1mo pos6 | alpha-synuclein knockout | 1 month |
SA331508 | aKO1mo neg4 | alpha-synuclein knockout | 1 month |
SA331509 | aKO1mo neg2 | alpha-synuclein knockout | 1 month |
SA331522 | aKO3mo pos5 | alpha-synuclein knockout | 3 months |
SA331523 | aKO3mo pos4 | alpha-synuclein knockout | 3 months |
SA331524 | aKO3mo pos3 | alpha-synuclein knockout | 3 months |
SA331525 | aKO3mo pos1 | alpha-synuclein knockout | 3 months |
SA331526 | aKO3mo pos2 | alpha-synuclein knockout | 3 months |
SA331527 | aKO3mo neg1 | alpha-synuclein knockout | 3 months |
SA331528 | aKO3mo pos6 | alpha-synuclein knockout | 3 months |
SA331529 | aKO3mo neg4 | alpha-synuclein knockout | 3 months |
SA331530 | aKO3mo neg5 | alpha-synuclein knockout | 3 months |
SA331531 | aKO3mo neg6 | alpha-synuclein knockout | 3 months |
SA331532 | aKO3mo neg3 | alpha-synuclein knockout | 3 months |
SA331533 | aKO3mo neg2 | alpha-synuclein knockout | 3 months |
SA331412 | Blank neg1 | NA | NA |
SA331413 | Std neg1 | NA | NA |
SA331414 | Std pos3 | NA | NA |
SA331415 | Blank neg2 | NA | NA |
SA331416 | Std pos2 | NA | NA |
SA331417 | Blank pos1 | NA | NA |
SA331418 | Std neg2 | NA | NA |
SA331419 | Std neg3 | NA | NA |
SA331420 | Std neg4 | NA | NA |
SA331421 | Std pos4 | NA | NA |
SA331422 | Blank pos2 | NA | NA |
SA331423 | Std pos1 | NA | NA |
SA331436 | WT10mo pos5 | Wild-type | 10 months |
SA331437 | WT10mo pos6 | Wild-type | 10 months |
SA331438 | WT10mo pos4 | Wild-type | 10 months |
SA331439 | WT10mo neg3 | Wild-type | 10 months |
SA331440 | WT10mo pos2 | Wild-type | 10 months |
SA331441 | WT10mo pos1 | Wild-type | 10 months |
SA331442 | WT10mo pos3 | Wild-type | 10 months |
SA331443 | WT10mo neg5 | Wild-type | 10 months |
SA331444 | WT10mo neg2 | Wild-type | 10 months |
SA331445 | WT10mo neg4 | Wild-type | 10 months |
SA331446 | WT10mo neg1 | Wild-type | 10 months |
SA331447 | WT10mo neg6 | Wild-type | 10 months |
SA331424 | WT1mo neg4 | Wild-type | 1 month |
SA331425 | WT1mo neg5 | Wild-type | 1 month |
SA331426 | WT1mo neg1 | Wild-type | 1 month |
Collection:
Collection ID: | CO003160 |
Collection Summary: | Synaptic vesicle were isolated by subcellular fractionation and concentrated |
Sample Type: | Brain |
Treatment:
Treatment ID: | TR003176 |
Treatment Summary: | No treatments |
Sample Preparation:
Sampleprep ID: | SP003173 |
Sampleprep Summary: | Synaptic vesicles were isolated from six animals each of 1-month, 3-month, and 10-month old wild-type mice (JAX strain #: 000664), α-synuclein knockout mice (JAX strain #: 023837), and α-synuclein BAC mice (JAX strain #: 023837) using subcellular fractionation. Vesicles were concentrated using 3 kDa cutoff Amicon ultra centrifugal devices (Millipore). Pellets were resuspended in 100 µl water and homogenized. Protein concentration was determined using absorption at 280 nm. Samples were adjusted to the same concentration to a final volume of 200 µl in 50% methanol. All samples were mixed with a panel of 15 lipid internal standards (Splash LipidMix lot#330707), followed by lipid extraction as previously reported (*1). Lipids were analyzed by LC-MS/MS on an Accucore C30 column (2.1 mm id x 150mm) under both positive and negative ion modes. Raw data files were searched and processed using LipidSearch 5.1 (Thermo Scientific) and normalized against the known amount of internal standard lipids for each sample, allowing for reliably quantitative measurements of all 15 categories of lipids (*1). References: 1. Bhawal, R., Fu, Q., Anderson, E.T., Gibson, G.E., and Zhang, S. (2021). Serum Metabolomic and Lipidomic Profiling Reveals Novel Biomarkers of Efficacy for Benfotiamine in Alzheimer's Disease. Int J Mol Sci 22. |
Combined analysis:
Analysis ID | AN005004 | AN005005 |
---|---|---|
Analysis type | MS | MS |
Chromatography type | Reversed phase | Reversed phase |
Chromatography system | Thermo Vanquish | Thermo Vanquish |
Column | Thermo Accucore C30 (150 x 2.1mm,2.6um) | Thermo Accucore C30 (150 x 2.1mm,2.6um) |
MS Type | ESI | ESI |
MS instrument type | Orbitrap | Orbitrap |
MS instrument name | Thermo Q Exactive HF hybrid Orbitrap | Thermo Q Exactive HF hybrid Orbitrap |
Ion Mode | POSITIVE | NEGATIVE |
Units | area | area |
Chromatography:
Chromatography ID: | CH003781 |
Instrument Name: | Thermo Vanquish |
Column Name: | Thermo Accucore C30 (150 x 2.1mm,2.6um) |
Column Temperature: | 55 |
Flow Gradient: | 0-4 min: 32% B; 4-5 min: 45% B; 5-8 min: 52% B; 8-11 min: 66% B; 11-14 min: 66% B; 14-18 min: 70% B, 18-21 min: 75% B; 21-25.01 min, 97% B; 25.01-30 min: 32% B |
Flow Rate: | 0.26 ml/min |
Solvent A: | 60% ACN, 40% H2O, 10 mM ammonium formate with 0.1% formic acid |
Solvent B: | 90% IPA, 10% ACN, 10 mM ammonium formate with 0.1% formic acid |
Chromatography Type: | Reversed phase |
MS:
MS ID: | MS004744 |
Analysis ID: | AN005004 |
Instrument Name: | Thermo Q Exactive HF hybrid Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
MS Comments: | ESI voltage: 4kV Sheath gas flow rate: 50 (AU) Aux gas flow rate: 5 Sweep gas flow rate: 1 capillary temperature: 320°C S-Lens RF level: 60 Aux gas heater temperature: 350°C |
Ion Mode: | POSITIVE |
MS ID: | MS004745 |
Analysis ID: | AN005005 |
Instrument Name: | Thermo Q Exactive HF hybrid Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
MS Comments: | ESI voltage: 4kV Sheath gas flow rate: 50 (AU) Aux gas flow rate: 5 Sweep gas flow rate: 1 capillary temperature: 320°C S-Lens RF level: 60 Aux gas heater temperature: 350°C |
Ion Mode: | NEGATIVE |